EP Patent

EP3372584A1 — Process for the preparation of a diarylthiohydantoin compound

Assigned to Aragon Pharmaceuticals Inc · Expires 2018-09-12 · 8y expired

What this patent protects

Disclosed are processes to prepare intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.

USPTO Abstract

Disclosed are processes to prepare intermediates for the preparation of compound (X), which is currently being investigated for the treatment of prostate cancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP3372584A1
Jurisdiction
EP
Classification
—
Expires
2018-09-12
Drug substance claim
No
Drug product claim
No
Assignee
Aragon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.